If you could bring in former Amgen ($AMGN) CEO Kevin Sharer as a consultant, what would he say? Don't hire consultants--at least not when your top executives are codifying the sorts of behaviors they want to see in company leaders. Report
| Download Today | Sponsored by: BaxterWhile the development of an aqueous solution formulation may be preferred over a lyophilized product, it is useful to initially pursue a dual path and develop drug product formulations for both a sterile solution and a freeze-dried solid presentation. Learn More Today!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!